S&P 500
(0.02%) 5 071.63 points
Dow Jones
(-0.11%) 38 461 points
Nasdaq
(0.10%) 15 713 points
Oil
(0.08%) $82.88
Gas
(-0.30%) $1.648
Gold
(-0.52%) $2 326.30
Silver
(-0.81%) $27.13
Platinum
(-0.55%) $910.80
USD/EUR
(-0.09%) $0.934
USD/NOK
(-0.07%) $10.98
USD/GBP
(-0.02%) $0.802
USD/RUB
(-0.02%) $92.30

Realtime updates for Axsome Therapeutics Inc [AXSM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
54.76%
return -6.95%
SELL
26.83%
return 20.76%
Last Updated24 Apr 2024 @ 16:00

-2.61% $ 71.17

SELL 518 min ago

@ $70.67

Issued: 24 Apr 2024 @ 15:43


Return: 0.71%


Previous signal: Apr 24 - 12:02


Previous signal: Buy


Return: -0.80 %

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States...

Stats
Today's Volume 583 547
Average Volume 724 903
Market Cap 3.37B
EPS $0 ( 2024-02-20 )
Next earnings date ( $-1.210 ) 2024-05-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -13.50
ATR14 $3.22 (4.53%)
Insider Trading
Date Person Action Amount type
2024-04-01 Jacobson Mark L. Buy 24 662 Common Stock
2024-04-01 Jacobson Mark L. Sell 24 662 Stock Option (Right to Buy)
2024-04-01 Jacobson Mark L. Sell 24 662 Common Stock
2024-03-14 Jeffs Roger Buy 16 976 Common Stock
2024-03-14 Jeffs Roger Buy 13 000 Common Stock
INSIDER POWER
55.07
Last 99 transactions
Buy: 2 269 939 | Sell: 680 650

Volume Correlation

Long: 0.78 (moderate)
Short: -0.70 (moderate negative)
Signal:(66) Neutral

Axsome Therapeutics Inc Correlation

10 Most Positive Correlations
MMAC0.888
BOCH0.879
MIRM0.876
RNEM0.87
BATRA0.869
SINO0.866
BATRK0.86
VIRI0.858
LMRKO0.854
RAM0.851
10 Most Negative Correlations
APOP-0.937
RMRM-0.915
TDAC-0.893
MAGS-0.891
CMLF-0.868
BHTG-0.861
VTRU-0.848
GAINL-0.847
TRIT-0.845
SSTI-0.836

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Axsome Therapeutics Inc Correlation - Currency/Commodity

The country flag -0.27
( neutral )
The country flag -0.15
( neutral )
The country flag 0.00
( neutral )
The country flag 0.18
( neutral )
The country flag -0.80
( moderate negative )
The country flag 0.54
( weak )

Axsome Therapeutics Inc Financials

Annual 2023
Revenue: $270.60M
Gross Profit: $237.70M (87.84 %)
EPS: $-5.27
Q4 2023
Revenue: $71.53M
Gross Profit: $64.15M (89.69 %)
EPS: $-2.08
Q3 2023
Revenue: $57.79M
Gross Profit: $51.26M (88.70 %)
EPS: $-1.320
Q2 2023
Revenue: $46.70M
Gross Profit: $42.10M (90.15 %)
EPS: $-1.540

Financial Reports:

No articles found.

Axsome Therapeutics Inc

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators